Tag: TSXV:KHRN

April 3, 2020

Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update

Khiron Life Sciences (TSXV:KHRN) announces that it will report Q4 and year-end financial results on April 28, 2020 and webcast...
April 1, 2020

Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University

Agreement with Tecnologico de Monterrey, a leading Latin American university (Third Ranked in Latin America) in Mexico brings Khiron´s online...
March 31, 2020

Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia

Khiron Life Sciences Corp. has launched its teleconsultation services to meet essential patient needs during the current COVID-19 pandemic.
March 20, 2020
March 20, 2020

Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update

Khiron Life Sciences Corp. has received certification of Good Elaboration Practices for Magistral Preparations with Cannabis (GEP).
March 6, 2020

Khiron Poised to Enter Medical Cannabis Market in Peru

Khiron Life Sciences Corp. has entered into an exclusive 2-year agreement with Farmacia Universal S.A.C. of Perú.
March 1, 2020

Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia

Khiron Life Sciences Corp. (TSXV: KHRN, OTCQB: KHRNF, Frankfurt: A2JMZC) has received manufacturing quotas from the Colombian Technical Quotas Group.